Corvino Frank 4
4 · HEALTHEQUITY, INC. · Filed Jun 25, 2021
Insider Transaction Report
Form 4
Corvino Frank
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2021-06-23−4,762→ 3,608 totalExercise: $14.00Exp: 2024-07-30→ Common Stock (4,762 underlying) - Sale
Common Stock
2021-06-23$83.75/sh−100$8,375→ 2,266 total - Sale
Common Stock
2021-06-23$83.08/sh−4,612$383,160→ 2,416 total - Sale
Common Stock
2021-06-23$83.74/sh−150$12,561→ 2,266 total - Sale
Common Stock
2021-06-23$83.09/sh−4,073$338,410→ 2,366 total - Exercise/Conversion
Common Stock
2021-06-23$14.00/sh+4,762$66,668→ 7,028 total
Holdings
- 6,482
Stock Option (right to buy)
Exercise: $21.27Exp: 2026-02-01→ Common Stock (6,482 underlying)
Footnotes (5)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.67 to $83.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (1), (2), and (3) of this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.72 to $83.77, inclusive.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.68 to $83.63, inclusive.
- [F4]The option is immediately exercisable.
- [F5]Corrects an error in the number of stock options reported as beneficially owned in a previous Form 4 filing.